308 related articles for article (PubMed ID: 28696232)
1. Community Composition Determines Activity of Antibiotics against Multispecies Biofilms.
Tavernier S; Crabbé A; Hacioglu M; Stuer L; Henry S; Rigole P; Dhondt I; Coenye T
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696232
[TBL] [Abstract][Full Text] [Related]
2. Decreased susceptibility of Streptococcus anginosus to vancomycin in a multispecies biofilm is due to increased thickness of the cell wall.
Tavernier S; Sass A; De Bruyne M; Baeke F; De Rycke R; Crabbé A; Vandecandelaere I; Van Nieuwerburgh F; Coenye T
J Antimicrob Chemother; 2018 Sep; 73(9):2323-2330. PubMed ID: 29901811
[TBL] [Abstract][Full Text] [Related]
3.
Orazi G; O'Toole GA
mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
Orazi G; Ruoff KL; O'Toole GA
mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
[No Abstract] [Full Text] [Related]
5. A Pseudomonas aeruginosa Antimicrobial Affects the Biogeography but Not Fitness of Staphylococcus aureus during Coculture.
Barraza JP; Whiteley M
mBio; 2021 Mar; 12(2):. PubMed ID: 33785630
[No Abstract] [Full Text] [Related]
6. Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms.
Orazi G; Jean-Pierre F; O'Toole GA
J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32661077
[TBL] [Abstract][Full Text] [Related]
7. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.
Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ
Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222
[TBL] [Abstract][Full Text] [Related]
8. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
[TBL] [Abstract][Full Text] [Related]
9. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility of cystic fibrosis lung microbiome members in a multispecies biofilm.
Vandeplassche E; Sass A; Ostyn L; Burmølle M; Kragh KN; Bjarnsholt T; Coenye T; Crabbé A
Biofilm; 2020 Dec; 2():100031. PubMed ID: 33447816
[TBL] [Abstract][Full Text] [Related]
11. Activity of disinfectants against multispecies biofilms formed by Staphylococcus aureus, Candida albicans and Pseudomonas aeruginosa.
Kart D; Tavernier S; Van Acker H; Nelis HJ; Coenye T
Biofouling; 2014; 30(3):377-83. PubMed ID: 24579656
[TBL] [Abstract][Full Text] [Related]
12. Influence of biofilm growth age, media, antibiotic concentration and exposure time on Staphylococcus aureus and Pseudomonas aeruginosa biofilm removal in vitro.
Chen X; Thomsen TR; Winkler H; Xu Y
BMC Microbiol; 2020 Aug; 20(1):264. PubMed ID: 32831025
[TBL] [Abstract][Full Text] [Related]
13. Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.
Jennings JA; Carpenter DP; Troxel KS; Beenken KE; Smeltzer MS; Courtney HS; Haggard WO
Clin Orthop Relat Res; 2015 Jul; 473(7):2270-82. PubMed ID: 25604874
[TBL] [Abstract][Full Text] [Related]
14. Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model.
Rodríguez-Sevilla G; García-Coca M; Romera-García D; Aguilera-Correa JJ; Mahíllo-Fernández I; Esteban J; Pérez-Jorge C
Int J Med Microbiol; 2018 Apr; 308(3):413-423. PubMed ID: 29555180
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms.
Toté K; Berghe DV; Deschacht M; de Wit K; Maes L; Cos P
Int J Antimicrob Agents; 2009 Jun; 33(6):525-31. PubMed ID: 19179053
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus.
Singh V; Arora V; Alam MJ; Garey KW
Antimicrob Agents Chemother; 2012 Aug; 56(8):4360-4. PubMed ID: 22664967
[TBL] [Abstract][Full Text] [Related]
17. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970
[TBL] [Abstract][Full Text] [Related]
19. D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Sanchez CJ; Akers KS; Romano DR; Woodbury RL; Hardy SK; Murray CK; Wenke JC
Antimicrob Agents Chemother; 2014 Aug; 58(8):4353-61. PubMed ID: 24841260
[TBL] [Abstract][Full Text] [Related]
20. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
Field TR; White A; Elborn JS; Tunney MM
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
